Nektar Therapeutics Competitors and Similar CompaniesClear all
Nektar Therapeutics's competitors and similar companies include Stingray Therapeutics, Aura Biosciences and Signpath Pharma.
 Stingray Therapeutics Stingray Therapeutics is a company that specializes in immunotherapy to fight cancer. |  Aura Biosciences Aura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology. |  Signpath Pharma SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia. | ||
Founding Date | Founding Date 1990 | Founding Date 2018 | Founding Date 2009 | Founding Date 2006 |
Type | Type Public | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Houston, US HQ | Locations Cambridge, US HQ | Locations Sandy, US HQ |
Employees | Employees 61821% increase | Employees 7 | Employees 42 | Employees 11 |
Valuation ($) | Valuation ($) 233.8 m | Valuation ($) N/A | Valuation ($) 544.2 m | Valuation ($) N/A |
Financial | ||||
Net income | Net income ($164.1m) (FY, 2025) | Net income N/A | Net income ($106.2m) (FY, 2025) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 45m | Total funding raised N/A | Total funding raised $ 213.9m | Total funding raised $ 5.3m |
For sources of this data, please see the company profile
View Company Profiles
Stingray Therapeutics
HQ
Houston, US
Employees
7
Stingray Therapeutics is a company that specializes in immunotherapy to fight cancer.
View companyAura Biosciences
HQ
Cambridge, US
Employees
42
Aura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology.
View companySignpath Pharma
HQ
Sandy, US
Employees
11
SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia.
View company